CORRESP Filing
Nutex Health Inc.
Date: April 29, 2025 · CIK: 0001479681 · Accession: 0001079973-25-000710
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286554
Letter
Correspondence
NUTEX HEALTH INC.
6030 S. Rice, Suite C
Houston, TX 77081
VIA EDGAR
April 29, 2025
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3561
Re: Nutex Health Inc. Registration Statement on Form S-3 File No. 333-286554
Ladies and Gentlemen:
On behalf of Nutex Health Inc., and pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned hereby requests that the effective date of the above referenced Registration Statement on Form S-3 be accelerated to 4:00 p.m., Washington, D.C. time, on Thursday, May 1, 2025, or as soon as practicable thereafter.
Thank you for your assistance in this matter. If you need any additional information, please contact Gislar Donnenberg of Troutman Pepper Locke LLP at (713) 226-1351.
Very truly yours,
Nutex Health Inc.
Show Raw Text
CORRESP 1 filename1.htm Correspondence NUTEX HEALTH INC. 6030 S. Rice, Suite C Houston, TX 77081 VIA EDGAR April 29, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3561 Re: Nutex Health Inc. Registration Statement on Form S-3 File No. 333-286554 Ladies and Gentlemen: On behalf of Nutex Health Inc., and pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned hereby requests that the effective date of the above referenced Registration Statement on Form S-3 be accelerated to 4:00 p.m., Washington, D.C. time, on Thursday, May 1, 2025, or as soon as practicable thereafter. Thank you for your assistance in this matter. If you need any additional information, please contact Gislar Donnenberg of Troutman Pepper Locke LLP at (713) 226-1351. Very truly yours, Nutex Health Inc. By: /s/ Elisa Luqman Name: Elisa Luqman Title: Chief Legal Officer (SEC)